Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
4-fold
11%
Abdominal Aortic Aneurysm Repair
11%
Analysis Matrix
11%
Aneurysm
11%
Aneurysm Development
11%
Aneurysm Expansion
11%
Aneurysm Wall
11%
Aortic Wall
44%
Clinical Management
11%
Clinically Significant
11%
Collagen
11%
Connective Tissue
11%
Degenerative Conditions
11%
Doxycycline
66%
Elastin
11%
Experimental Animal Models
11%
Life-threatening
11%
Local Production
11%
Matrix Metalloproteinase Inhibitors
100%
Matrix metalloproteinase-2 (MMP-2)
66%
Matrix metalloproteinase-9 (MMP-9)
33%
Pleiotropic Effects
11%
Preoperative Treatment
11%
Progressive Degradation
11%
Prospective Randomized Clinical Trial
100%
Quantitative PCR
11%
Rupture Risk
11%
Ruptured Abdominal Aortic Aneurysm (rAAA)
100%
Short-term Treatment
11%
Southern Blot Analysis
11%
Tetracycline Derivatives
11%
Timing of Surgery
11%
Tissue Degradation
11%
Tissue Explants
11%
Untreated Patients
11%
Vascular Cells
11%
Biochemistry, Genetics and Molecular Biology
Animal Model
20%
Elastin
20%
Experimental Animal
20%
Explant
20%
Gelatinase A
60%
Gelatinase B
60%
Matrix Metalloproteinase
100%
Matrix Metalloproteinase Inhibitor
40%
MMP2
60%
MMP9
60%
Pleiotropy
20%
Randomized Clinical Trial
100%
Reverse Transcription Polymerase Chain Reaction
20%
Southern Blotting
20%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Aortic Aneurysm
100%
Aneurysm
40%
Doxycycline
60%
Elastin
10%
Experimental Animal
10%
Gelatinase A
30%
Gelatinase B
30%
Matrix Metalloproteinase
100%
Matrix Metalloproteinase Inhibitor
20%
Randomized Clinical Trial
100%
Tetracycline
10%